Citadel Advisors - PYXIS ONCOLOGY INC ownership

PYXIS ONCOLOGY INC's ticker is and the CUSIP is 747324101. A total of 46 filers reported holding PYXIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PYXIS ONCOLOGY INC
ValueSharesWeighting
Q1 2023$108,787
-94.8%
27,129
-98.3%
0.00%
Q4 2022$2,094,150
-30.5%
1,562,798
+2.1%
0.00%
-100.0%
Q3 2022$3,015,000
-16.7%
1,530,785
+0.6%
0.00%0.0%
Q2 2022$3,620,000
-40.3%
1,520,936
-0.1%
0.00%0.0%
Q1 2022$6,064,000
-63.2%
1,522,498
+0.1%
0.00%
-66.7%
Q4 2021$16,482,0001,521,6170.00%
Other shareholders
PYXIS ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 645,149$1,535,0000.86%
TANG CAPITAL MANAGEMENT LLC 1,379,080$3,282,0000.50%
Newtyn Management, LLC 800,000$1,904,0000.36%
BVF INC/IL 2,938,851$6,994,0000.34%
Cormorant Asset Management, LP 668,854$1,592,0000.12%
Laurion Capital Management LP 3,170,803$7,547,0000.12%
Perceptive Advisors 1,528,812$3,639,0000.11%
Logos Global Management LP 220,434$525,0000.10%
Tekla Capital Management LLC 708,303$1,686,0000.07%
RA Capital Management 953,393$2,269,0000.06%
View complete list of PYXIS ONCOLOGY INC shareholders